Enrichment Program. The mission of the UCSF DRC Enrichment Program is to facilitate the exchange of research information among investigators in diabetes at UCSF, as well as to promote scientific exchange with members of the national and international diabetes research community. The UCSF DRC Enrichment Program Director implements the Program's mission by working with an oversight committee that includes the Center Director and the principal investigators of relevant, NIDDK sponsored, T32 training grants. The long-term goal of the UCSF DRC Enrichment Program is to foster a highly collaborative environment that will advance and promote successful basic, translational and clinical diabetes research at UCSF. The specific objectives of the program are to: 1) facilitate the exchange of research information and discussion among investigators, students, fellows and staff participating in the DRC. 2) enhance the visibility of the DRC and the work of the DRC researchers within the broader UCSF research community. 3) facilitate interactions and collaborations with UCSF investigators in other fields at UCSF. 4) promote scientific exchange with members of the national and international diabetes research community. 5) enhance the institutional training environment in diabetes related fields. These objectives of the UCSF DRC Enrichment Program are met through the organization and/or co- sponsoring of diabetes-oriented educational weekly activities such as the Diabetes Center Seminars and the Endocrine Grand Rounds as well as annual venues such as the UCSF Diabetes Center retreat and an annual post-graduate CME diabetes course. The UCSF DRC Enrichment Program coordinates with other UCSF seminar series to bring in high visibility speakers who expose the broader UCSF and San Francisco Bay area to cutting edge diabetes research. The DRC supports also the annual UCSF Diabetes Center Visiting Professor in which an invited guest which a broad research focus in diabetes presents three lectures in different seminar series. DRC participation in these broader seminar series engages the UCSF scientific community to consider the applications of their current studies to diabetes research. This helps to foster multidisciplinary approaches to diabetes research and to attract new investigators or investigators with relevant expertise to diabetes research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK063720-11
Application #
8874803
Study Section
Special Emphasis Panel (ZDK1-GRB-S (J4))
Project Start
Project End
Budget Start
2015-04-01
Budget End
2016-03-31
Support Year
11
Fiscal Year
2015
Total Cost
$97,871
Indirect Cost
$36,074
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485
Corbit, Kevin C; Camporez, João Paulo G; Edmunds, Lia R et al. (2018) Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling. Diabetes 67:208-221
Mocciaro, Annamaria; Roth, Theodore L; Bennett, Hayley M et al. (2018) Light-activated cell identification and sorting (LACIS) for selection of edited clones on a nanofluidic device. Commun Biol 1:41
Miranda, Diego A; Krause, William C; Cazenave-Gassiot, Amaury et al. (2018) LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity. JCI Insight 3:
Greenstein, R A; Jones, Stephen K; Spivey, Eric C et al. (2018) Noncoding RNA-nucleated heterochromatin spreading is intrinsically labile and requires accessory elements for epigenetic stability. Elife 7:
Chamberlain, Chester E; German, Michael S; Yang, Katherine et al. (2018) A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors. Mol Cancer Ther 17:2702-2709
Lee, Jessica; Pappalardo, Zachary; Chopra, Deeksha Gambhir et al. (2018) A Genetic Interaction Map of Insulin Production Identifies Mfi as an Inhibitor of Mitochondrial Fission. Endocrinology 159:3321-3330
Sneddon, Julie B; Tang, Qizhi; Stock, Peter et al. (2018) Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges. Cell Stem Cell 22:810-823
Siljee, Jacqueline E; Wang, Yi; Bernard, Adelaide A et al. (2018) Subcellular localization of MC4R with ADCY3 at neuronal primary cilia underlies a common pathway for genetic predisposition to obesity. Nat Genet 50:180-185
Hennings, Thomas G; Chopra, Deeksha G; DeLeon, Elizabeth R et al. (2018) In Vivo Deletion of ?-Cell Drp1 Impairs Insulin Secretion Without Affecting Islet Oxygen Consumption. Endocrinology 159:3245-3256

Showing the most recent 10 out of 531 publications